UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Repeatability and predictive value of lactate threshold concepts in endurance sports

PloS one, 2018-11, Vol.13 (11), p.e0206846-e0206846

2018

Volltextzugriff (PDF)

Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development

British journal of clinical pharmacology, 2014-06, Vol.77 (6), p.947-957

2014

Volltextzugriff (PDF)

Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial

British journal of clinical pharmacology, 2015-12, Vol.80 (6), p.1350-1361

2015

Volltextzugriff (PDF)

Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17

Oncotarget, 2016-05, Vol.7 (22), p.32144-32155

2016

Volltextzugriff (PDF)

Accelerating vaccine trial conduct in a pandemic with a hot spot‐based inclusion strategy using trial and epidemic simulation

Clinical and translational science, 2021-11, Vol.14 (6), p.2391-2398

2021

Volltextzugriff (PDF)

Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics

Clinical pharmacokinetics, 2015-02, Vol.54 (2), p.209-219

2015

Volltextzugriff (PDF)

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

The lancet respiratory medicine, 2013-11, Vol.1 (9), p.714-727

2013

Volltextzugriff (PDF)

Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol

Journal of psychopharmacology (Oxford), 2019-07, Vol.33 (7), p.791-800

2019

Volltextzugriff (PDF)

Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk–benefit

British journal of clinical pharmacology, 2013-06, Vol.75 (6), p.1406-1421

2013

Volltextzugriff (PDF)

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

International journal of molecular sciences, 2019-09, Vol.20 (19), p.4710

2019

Volltextzugriff (PDF)

Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects

Sports medicine (Auckland), 2019-04, Vol.49 (4), p.525-539

2019

Volltextzugriff (PDF)

Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty

Clinical and translational science, 2023-02, Vol.16 (2), p.224-235

2023

Volltextzugriff (PDF)

De‐risking Clinical Trials: The BIAL Phase I Trial in Foresight

Clinical pharmacology and therapeutics, 2022-02, Vol.111 (2), p.362-365

2022

Volltextzugriff (PDF)

Development and Technical Validation of a Smartphone-Based Cry Detection Algorithm

Frontiers in pediatrics, 2021-04, Vol.9, p.651356-651356

2021

Volltextzugriff (PDF)

On authorship in the BJCP

British journal of clinical pharmacology, 2017-10, Vol.83 (10), p.2127-2130

Cohen, Adam F.

2017

Volltextzugriff (PDF)

Implications of the BIA‐102474‐101 study for review of first‐into‐human clinical trials

British journal of clinical pharmacology, 2016-04, Vol.81 (4), p.582-586

2016

Volltextzugriff (PDF)

Sensitivity and specificity of detection methods for erythropoietin doping in cyclists

Drug testing and analysis, 2019-09, Vol.11 (9), p.1290-1301

2019

Volltextzugriff (PDF)

Disproportional inflation of clinical trial costs: why we should care, and what we should do about it

Nature reviews. Drug discovery, 2024-02, Vol.23 (2), p.85-86

2024

Volltextzugriff (PDF)

Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity

Digital biomarkers, 2022-03, Vol.6 (1), p.19-30

2022

Volltextzugriff (PDF)

Question-based drug development and the value of novel treatments

Expert review of pharmacoeconomics & outcomes research, 2024-10, p.1-4

2024

Volltextzugriff (PDF)

A Pilot Study Evaluating the Physiological Parameters of Performance-Induced Stress in Undergraduate Music Students

Digital biomarkers, 2018-01, Vol.1 (2), p.118-125

2018

Volltextzugriff (PDF)

Dealing with doping. A plea for better science, governance and education

British journal of clinical pharmacology, 2022-02, Vol.88 (2), p.566-578

2022

Volltextzugriff (PDF)

The British Journal of Clinical Pharmacology: The first 50 years

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.4-11

2024

Volltextzugriff (PDF)

A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer

Clinical cancer research, 2016-06, Vol.22 (12), p.2929-2938

2016

Volltextzugriff (PDF)

Effect of an NK1/NK2 Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma

American journal of respiratory and critical care medicine, 2007-03, Vol.175 (5), p.450-457

2007

Volltextzugriff (PDF)

1 – 25 von 688

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(641)
Mit Volltextzugriff
(568)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Repeatability and predictive value of lactate threshold concepts in endurance sports

Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development

Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial

Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17

Accelerating vaccine trial conduct in a pandemic with a hot spot‐based inclusion strategy using trial and epidemic simulation

Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol

Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk–benefit

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?

Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects

Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty

De‐risking Clinical Trials: The BIAL Phase I Trial in Foresight

Development and Technical Validation of a Smartphone-Based Cry Detection Algorithm

On authorship in the BJCP

Implications of the BIA‐102474‐101 study for review of first‐into‐human clinical trials

Sensitivity and specificity of detection methods for erythropoietin doping in cyclists

Disproportional inflation of clinical trial costs: why we should care, and what we should do about it

Objective Home-Monitoring of Physical Activity, Cardiovascular Parameters, and Sleep in Pediatric Obesity

Question-based drug development and the value of novel treatments

A Pilot Study Evaluating the Physiological Parameters of Performance-Induced Stress in Undergraduate Music Students

Dealing with doping. A plea for better science, governance and education

The British Journal of Clinical Pharmacology: The first 50 years

A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer

Effect of an NK1/NK2 Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma

Suchergebnisse filtern